Vetter Pharma

Vetter Pharma Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

VetterPharma key operating metrics including New Drugs Approved (USA).

New Drugs Approved (USA)

26.0%

FY, 2022

New Drugs Approved (Germany)

6.5%

FY, 2022

Commercial Products Developed

110

5.8%

FY, 2022

Operating Metrics

Metrics	FY, 2020	FY, 2021	FY, 2022
New Drugs Approved (USA)	53	50	37
New Drugs Approved (Germany)	32	46	49
Commercial Products Developed		104	110
Customers		150	125